Molecular Biology of the Cell click for CBE Life Science Education Page

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Originally published as MBC in Press, 10.1091/mbc.E06-07-0617 on March 1, 2007

Vol. 18, Issue 5, 1768-1780, May 2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Materials
Right arrow All Versions of this Article:
E06-07-0617v1
18/5/1768    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cardone, R. A.
Right arrow Articles by Reshkin, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cardone, R. A.
Right arrow Articles by Reshkin, S. J.

The NHERF1 PDZ2 Domain Regulates PKA–RhoA–p38-mediated NHE1 Activation and Invasion in Breast Tumor CellsFormula Formula

Rosa A. Cardone*, Antonia Bellizzi*,{dagger}, Giovanni Busco*, Edward J. Weinman{ddagger},§, Maria E. Dell'Aquila||, Valeria Casavola*, Amalia Azzariti{dagger}, Anita Mangia{dagger}, Angelo Paradiso{dagger}, and Stephan J. Reshkin*

Departments of *General and Environmental Physiology and ||Animal Production, University of Bari, 70126 Bari, Italy; {dagger}Clinical Experimental Oncology Laboratory, National Cancer Institute Giovanni Paolo II, 70126 Bari, Italy; {ddagger}Department of Medicine, University of Maryland School of Medicine, Baltimore, MD 21201; and §Medical Service, Department of Veterans Affairs Medical Center, Baltimore, MD 21201

Submitted July 21, 2006; Revised February 6, 2007; Accepted February 21, 2007
Monitoring Editor: John Cleveland

Understanding the signal transduction systems governing invasion is fundamental for the design of therapeutic strategies against metastasis. Na+/H+ exchanger regulatory factor (NHERF1) is a postsynaptic density 95/disc-large/zona occludens (PDZ) domain-containing protein that recruits membrane receptors/transporters and cytoplasmic signaling proteins into functional complexes. NHERF1 expression is altered in breast cancer, but its effective role in mammary carcinogenesis remains undefined. We report here that NHERF1 overexpression in human breast tumor biopsies is associated with metastatic progression, poor prognosis, and hypoxia-inducible factor-1{alpha} expression. In cultured tumor cells, hypoxia and serum deprivation increase NHERF1 expression, promote the formation of leading-edge pseudopodia, and redistribute NHERF1 to these pseudopodia. This pseudopodial localization of NHERF1 was verified in breast biopsies and in three-dimensional Matrigel culture. Furthermore, serum deprivation and hypoxia stimulate the Na+/H+ exchanger, invasion, and activate a protein kinase A (PKA)-gated RhoA/p38 invasion signal module. Significantly, NHERF1 overexpression was sufficient to induce these morphological and functional changes, and it potentiated their induction by serum deprivation. Functional experiments with truncated and binding groove-mutated PDZ domain constructs demonstrated that NHERF1 regulates these processes through its PDZ2 domain. We conclude that NHERF1 overexpression enhances the invasive phenotype in breast cancer cells, both alone and in synergy with exposure to the tumor microenvironment, via the coordination of PKA-gated RhoA/p38 signaling.


This article was published online ahead of print in MBC in Press (http://www.molbiolcell.org/cgi/doi/10.1091/mbc.E06-07-0617) on March 1, 2007.

Formula Formula The online version of this article contains supplemental material at MBC Online (http://www.molbiolcell.org).

These authors contributed equally to this work.

Address correspondence to: S. J. Reshkin (reshkin{at}biologia.uniba.it)




This article has been cited by other articles:


Home page
Cancer Res.Home page
A. P. Kumar, A. L. Quake, M. K. X. Chang, T. Zhou, K. S. Y. Lim, R. Singh, R. E. Hewitt, M. Salto-Tellez, S. Pervaiz, and M.-V. Clement
Repression of NHE1 Expression by PPAR{gamma} Activation Is a Potential New Approach for Specific Inhibition of the Growth of Tumor Cells In vitro and In vivo
Cancer Res., November 15, 2009; 69(22): 8636 - 8644.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
L. Fouassier, P. Rosenberg, M. Mergey, B. Saubamea, A. Claperon, N. Kinnman, N. Chignard, G. Jacobsson-Ekman, B. Strandvik, C. Rey, et al.
Ezrin-Radixin-Moesin-Binding Phosphoprotein (EBP50), an Estrogen-Inducible Scaffold Protein, Contributes to Biliary Epithelial Cell Proliferation
Am. J. Pathol., March 1, 2009; 174(3): 869 - 880.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Chiche, K. Ilc, J. Laferriere, E. Trottier, F. Dayan, N. M. Mazure, M. C. Brahimi-Horn, and J. Pouyssegur
Hypoxia-Inducible Carbonic Anhydrase IX and XII Promote Tumor Cell Growth by Counteracting Acidosis through the Regulation of the Intracellular pH
Cancer Res., January 1, 2009; 69(1): 358 - 368.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2007 by The American Society for Cell Biology. Terms of copyright protection, warranties, and disclaimers.